Events9th International Electronic Conference on Medicinal Chemistry
Event submissions
Published
with-doi10.3390/ECMC2023-15716 (registering DOI)
This submission belongs to the session S3. General of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarMaria Emília Sousa
Citation
Biljana Smit, Jovana Jovankic, Danijela Nikodijevic, Tanja V Soldatović, Cytotoxicity of novel heterometallic dinuclear complexes on colon carcinoma cell lines, in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15716
Share
Email
Facebook
Twitter
LinkedIn

Cytotoxicity of novel heterometallic dinuclear complexes on colon carcinoma cell lines

image
Tanja V Soldatović 1
Jovana Jovankic 2
Danijela Nikodijevic 2
Biljana Smit 3
1. Department of Chemical-Technological Sciences, State University of Novi Pazar, Vuka Karadžića bb, 36300 Novi Pazar, Serbia
2. Faculty of Science, University of Kragujevac, Radoja Domanovića 12 P.O. Box 60, 34000 Kragujevac, Serbia, Serbia
3. Institute for Information Technologies Kragujevac, Department of Science, University of Kragujevac, Jovana Cvijica bb, 34000 Kragujevac, Serbia, Serbia
Abstract

Cytotoxicity of four newly synthesized dinuclear complexes [{cis-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpy-Cl)}](ClO4)2, [{trans-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpy-Cl)}](ClO4)2, [{cis-PtCl(NH3)2(μ-pyrazine)ZnCl(terpy-Cl)}](ClO4)2 and [{trans-PtCl(NH3)2(μ-pyrazine)ZnCl(terpy-Cl)}](ClO4)2, derived from mononuclear [ZnCl(terpy-Cl)], (where terpy-Cl = 4’-chloro-2,2′:6′,2′′-terpyridine) were evaluated on two colon carcinoma cell lines, HCT-116 and SW-480.

The effect of investigated complexes at different concentrations (0.1, 1, 10, 50, 100, 200 μg/ml) on colon carcinoma cell lines (HCT-116 and SW-480) was examined with MTT assay, and the IC50 value was calculated, as a measure of cytotoxicity. Compared with the positive control (cisplatin), on SW-480 colon cancer cells, there is no significant citotoxicity of tested complexes and IC50 values are higher than 200 µg/ml. If we compare IC50 values between HCT-116 and SW-480 colon cancer cells, it is evident that HCT-116 cells are more sensitive on the treatment with these complexes. Tested complexes showed significant anticancer effect on HCT-116 colon carcinoma cell lines, but after 72 h of applied treatments. After 72 h, significant cytotoxic effect was evident only in HCT-116 cells after applied complexes [{cis-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpy-Cl)}](ClO4)2, [{trans-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpy-Cl)}](ClO4)2 and [{cis-PtCl(NH3)2(μ-pyrazine)ZnCl(terpy-Cl)}](ClO4)2. The best cytotoxic effect of all investigated complexes was pronounced after applying [{trans-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpy-Cl)}](ClO4)2 complex on HCT-116 colon cancer cells after 72 h (19.52±0.78 µg/ml).

In comparison with previously studied four analogues of these complexes but without chlorinated terpy ligand, cytotoxic effect of all complexes is lower. Obviously, the presence of the chloride in the structure of [ZnCl(terpy-Cl)] subunit of newly synthesized complexes influenced their behavior due to exchanged electronic communication between metal centers.

Keywords
cisplatin
Zn(II) complexes
terpy ligand
cytotoxic activity
colon carcinoma cell lines
Manuscript
9th-ECMC_Presentation_BSmit.pdf
In vitro antigenotoxicity of novel heterometallic dinuclear complexes
Chemical composition and anti-hemolytic activity of Algerian honey samples